Patents by Inventor Kiyoshi Mori

Kiyoshi Mori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140377786
    Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: September 10, 2014
    Publication date: December 25, 2014
    Inventors: Jonathan Matthew BARASCH, Prasad DEVARAJAN, Thomas L. NICKOLAS, Kiyoshi MORI
  • Patent number: 8916872
    Abstract: A method of forming a stacked low temperature diode and related devices. At least some of the illustrative embodiments are methods comprising forming a metal interconnect disposed within an inter-layer dielectric. The metal interconnect is electrically coupled to at least one underlying integrated circuit device. A barrier layer is deposited on the metal interconnect and the inter-layer dielectric. A semiconductor layer is deposited on the barrier layer. A metal layer is deposited on the semiconductor layer. The barrier layer, the semiconductor layer, and the metal layer are patterned. A low-temperature anneal is performed to induce a reaction between the patterned metal layer and the patterned semiconductor layer. The reaction forms a silicided layer within the patterned semiconductor layer. Moreover, the reaction forms a P-N junction diode.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: December 23, 2014
    Assignee: Inoso, LLC
    Inventors: Ziep Tran, Kiyoshi Mori, Giang Trung Dao, Michael Edward Ramon
  • Patent number: 8786130
    Abstract: A method of forming an electromechanical power switch for controlling power to integrated circuit (IC) devices and related devices. At least some of the illustrative embodiments are methods comprising forming at least one IC device on a front surface of a semiconductor substrate. The at least one IC device includes at least one circuit block and at least one power switch circuit. A dielectric layer is deposited on the IC device, and first and second electromechanical power switches are formed on the dielectric layer. The first power switch gates a voltage to the circuit block and the second power switch gates the voltage to the IC device. The first power switch is actuated by the power switch circuit, and the voltage to the circuit block is switched off. Alternatively, the second power switch is actuated by the power switch circuit, and the voltage to the IC device is switched off.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: July 22, 2014
    Assignee: INOSO, LLC
    Inventors: Kiyoshi Mori, Ziep Tran, Giang T. Dao, Michael E. Ramon
  • Publication number: 20140080155
    Abstract: Methods of assessing the ongoing kidney status in a subject afflicted with chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in fluid samples over time. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the urine and serum as a result of chronic renal tubule cell injury. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: November 25, 2013
    Publication date: March 20, 2014
    Inventors: Jonathan M. Barasch, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
  • Patent number: 8580696
    Abstract: Systems and methods for detecting watermark formations on semiconductor wafers are described. In one embodiment, a method comprises providing a semiconductor wafer having at least one watermark sensitive region fabricated thereon, subjecting the wafer to a wet processing step, enhancing a susceptibility to detection of at least one watermark formation created on the at least one watermark sensitive region, and detecting the at least one watermark formation. In another embodiment, a method comprises growing a first oxide layer on a surface of a semiconductor wafer, patterning a watermark sensitive structure on the first oxide layer, depositing a silicon layer over the first oxide layer, doping a region of the silicon layer over the watermark sensitive structure with an impurity to create a watermark sensitive region that is prone to retaining watermark formations as result of a wet processing step, and growing a second oxide layer over the silicon layer.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: November 12, 2013
    Assignee: Abound Limited
    Inventors: Kiyoshi Mori, Shu Ikeda, Gabriel Gebara
  • Publication number: 20130231409
    Abstract: A process for producing expanded polyolefin resin particles with use as a foaming agent of water contained in an aqueous dispersion medium. The process includes dispersing polyolefin resin particles together with the aqueous dispersion medium into a closed vessel; heating the polyolefin resin particles up to or above a softening temperature of the polyolefin resin particles and pressurizing the polyolefin resin particles; and releasing the polyolefin resin particles into a zone whose pressure is lower than an internal pressure of the closed vessel. The polyolefin resin particles are composed of a polyolefin resin composition including polyolefin resin, polyvalent alcohol and a foam nucleating agent.
    Type: Application
    Filed: April 11, 2013
    Publication date: September 5, 2013
    Applicant: Kaneka Corporation
    Inventors: Jun FUKUZAWA, Takamasa IMAI, Kiyoshi MORI
  • Publication number: 20130137122
    Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: January 23, 2013
    Publication date: May 30, 2013
    Inventors: Jonathan M. Barasch, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
  • Publication number: 20130040312
    Abstract: Methods of assessing the ongoing kidney status in a subject afflicted with chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in fluid samples over time. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the urine and serum as a result of chronic renal tubule cell injury. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: October 12, 2012
    Publication date: February 14, 2013
    Inventors: Jonathan Matthew BARASCH, Prasad DEVARAJAN, Thomas L. NICKOLAS, Kiyoshi MORI
  • Patent number: 8247376
    Abstract: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: August 21, 2012
    Assignees: The Trustees of Columbia University, Children's Hospital Medical Center
    Inventors: Jonathan M. Barasch, Prasad Devarajan, Kiyoshi Mori
  • Patent number: 7966842
    Abstract: The refrigerator includes a vegetable compartment (107) thermally insulated by a rear partition (111), and a mist generation department (139) for atomizing a mist into the vegetable compartment (107), and the mist generation department (139) includes a atomizing electrode (135) for atomizing the mist into the vegetable compartment (107), a voltage applicator (133) for applying a voltage to the atomizing electrode (135), and a cooling pin (134) coupled to the atomizing electrode (135), in which the atomizing electrode (135) is cooled to a temperature lower than the dew point by a outlet air-duct for freezer compartment (141), and the moisture in the air is cooled to condense dew on the atomizing electrode (135), and is atomized as a mist into the vegetable compartment (107), and dew can be condensed from moisture onto the atomizing electrode (135) stably and in a simple configuration, and the freshness of the food is enhanced while the reliability of the refrigerator is enhanced.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: June 28, 2011
    Assignee: Panasonic Corporation
    Inventors: Toyoshi Kamisako, Yoshihiro Ueda, Kazuya Nakanishi, Tadashi Adachi, Kazuyuki Hamada, Kiyotaka Tabira, Yasuyuki Okamoto, Kenichi Okabe, Masashi Yuasa, Kenichi Kakita, Kiyoshi Mori, Tosiaki Mamemoto, Katsunori Horii
  • Publication number: 20110143381
    Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: February 11, 2011
    Publication date: June 16, 2011
    Inventors: Jonathan Matthew Barasch, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
  • Publication number: 20100267850
    Abstract: Provided is a process for producing expanded polyolefin resin particles whose cells are not made nonuniform or extremely smaller as seen in conventional expanded particles, whose cell diameter and expansion ratio can be easily controlled independently, and which, when subjected to in-mold expansion molding, give in-mold expanded molded products satisfactory in fusibility and excellent in surface properties.
    Type: Application
    Filed: December 3, 2008
    Publication date: October 21, 2010
    Inventors: Toru Yoshida, Jun Fukuzawa, Takamasa Imai, Kiyoshi Mori, Hiroshi Tsuneishi
  • Publication number: 20100254970
    Abstract: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.
    Type: Application
    Filed: June 17, 2010
    Publication date: October 7, 2010
    Inventors: Jonathan M. BARASCH, Prasad Devarajan, Kiyoshi Mori
  • Publication number: 20100243767
    Abstract: A refrigerator includes: a storage compartment that is separated and heat-insulated from another area; an atomization device having an electrode unit that sprays mist into the storage compartment; and a protection unit that improves safety of a user.
    Type: Application
    Filed: November 5, 2008
    Publication date: September 30, 2010
    Applicant: PANASONIC CORPORATION
    Inventors: Kiyoshi Mori, Kenichi Kakita, Tosiaki Mamemoto, Yoshihiro Ueda, Toyoshi Kamisako, Takahiro Ueno
  • Publication number: 20100236269
    Abstract: A refrigerator that sprays a mist using an atomization apparatus includes an atomization state determination unit that determines an atomization state of an atomization unit. An operation of the atomization unit is controlled according to a signal determined by the atomization state determination unit. Thus, an appropriate amount of mist spray is performed according to the atomization state, so that improved spray accuracy can be attained.
    Type: Application
    Filed: November 5, 2008
    Publication date: September 23, 2010
    Applicant: PANASONIC CORPORATION
    Inventors: Tosiaki Mamemoto, Toyoshi Kamisako, Yoshihiro Ueda, Katsunori Horii, Kenichi Kakita, Tadashi Adachi, Kahoru Tsujimoto, Kiyoshi Mori
  • Publication number: 20100234765
    Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: May 21, 2010
    Publication date: September 16, 2010
    Inventors: Jonathan Matthew BARASCH, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
  • Patent number: 7776824
    Abstract: Use of neutrophil gelatinase-associated lipocalin (NGAL) as a therapeutic and in a method of treating, reducing, or ameliorating an injury selected from an ischemic injury, an ischemic-reperfusion injury, and a toxin-induced injury, to an organ in a patient. The invention includes administering to the patient NGAL in an amount effective to treat, reduce or ameliorate ischemic, ischemic-reperfusion, or toxin-induced injury to the organ, such as the kidney. A siderophore can be co-administered with the NGAL. The invention also relates to administering a sideophore to enhance a response to secretion of NGAL following an ischemic or toxin-induced injury to an organ in a patient.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: August 17, 2010
    Assignees: The Trustees of Columbia University, Children's Hospital Medical Center
    Inventors: Jonathan M. Barasch, Prasad Devarajan, Kiyoshi Mori
  • Publication number: 20100184089
    Abstract: A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.
    Type: Application
    Filed: March 30, 2010
    Publication date: July 22, 2010
    Inventors: Jonathan Matthew BARASCH, Prasad Devarajan, Thomas L. Nickolas, Kiyoshi Mori
  • Publication number: 20100147003
    Abstract: A mist atomizer is arranged in a first cooling duct including an outlet for vegetable compartment and an inlet for vegetable compartment. The mist atomizer is arranged near a gap of a lower basket and an upper basket. A refrigerator capable of efficiently collecting transpired moisture from stored food, sufficiently humidifying the interior of the basket, and having higher freshness maintaining property is provided.
    Type: Application
    Filed: April 25, 2008
    Publication date: June 17, 2010
    Inventors: Yoshihiro Ueda, Tadashi Adachi, Kazuya Nakanishi, Toyoshi Kamisako, Kahoru Tsujimoto, Kenichi Kakita, Tosiaki Mamemoto, Sachiko Kanehara, Kiyoshi Mori
  • Patent number: 7736962
    Abstract: A junction field effect transistor comprises an insulating layer formed in a substrate. A source region of a first conductivity type is formed on the insulating layer, and a drain region of the first conductivity type is formed on the insulating layer and spaced apart from the drain region. A channel region of the first conductivity type is located between the source region and the drain region and formed on the insulating layer. A gate region of the second conductivity type surrounds all surfaces of a length of the channel region such that the channel region is embedded within the gate region.
    Type: Grant
    Filed: January 7, 2009
    Date of Patent: June 15, 2010
    Assignee: SuVolta, Inc.
    Inventor: Kiyoshi Mori